أعرض في EDS

PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)

التفاصيل البيبلوغرافية
العنوان: PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
المؤلفون: Kent C. Shih, U. De Giorgi, Sergio Bracarda, D. Nava Rodrigues, Viorel Jinga, Steven Gendreau, Albert Font, Wai Y. Chan, Daniel J. Maslyar, Ivo Kocák, Liangxuan Zhang, J.S. de Bono, Wei Yu, J.A. Arranz Arija, Christophe Massard, Ruth Riisnaes, George Daniel Radavoi, Matthew Wongchenko
المصدر: Annals of Oncology. 27:vi243
بيانات النشر: Elsevier BV, 2016.
سنة النشر: 2016
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Akt inhibitor, Castration resistant, Ipatasertib, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, PTEN, In patient, Predictive biomarker, biology, business.industry, Abiraterone acetate, Hematology, medicine.disease, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, biology.protein, Cancer research, business
تدمد: 0923-7534
DOI: 10.1093/annonc/mdw372.02
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6dee6ee6f9121618daeef5ff9652fe75
https://doi.org/10.1093/annonc/mdw372.02
Rights: OPEN
رقم الانضمام: edsair.doi...........6dee6ee6f9121618daeef5ff9652fe75
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw372.02